Payers - PowerPoint PPT Presentation


Real-world Data (RWD) Market_Blog

Real-world Data (RWD) Market by Source (EMR, Claims, Pharmacy, Disease Registries), Application [Market Access, Drug Development & Approvals (Oncology, Neurology), Post Market Surveillance], End User (Pharma, Payers, Providers)

0 views • 2 slides


Real-world Data (RWD) Market_Blog

Real-world Data (RWD) Market by Source (EMR, Claims, Pharmacy, Disease Registries), Application [Market Access, Drug Development & Approvals (Oncology, Neurology), Post Market Surveillance], End User (Pharma, Payers, Providers)

0 views • 2 slides



Real-world Data (RWD) Market_Blog

Real-world data (RWD) has become a powerful tool in the life sciences industry by pharmaceutical, biotechnology, & medical device companies; healthcare payers; healthcare providers; and other end users (academic research institutions, patient advocacy groups, regulators

0 views • 2 slides


Leveraging Health-System Value for Pharmacy Payers/Manufacturers

Explore the comprehensive services and specialty pharmacy offerings of a health system, highlighting community impact, patient satisfaction, and therapeutic areas covered to demonstrate value to pharmacy payers and manufacturers. Discover the potential for collaboration, shared EHR benefits, and sup

0 views • 13 slides


Understanding Clinical Registries: Key Concepts and Implementation Strategies

Clinical registries play a crucial role in tracking real-world data and outcomes for various medical conditions. They are observational databases that collect data systematically for specific purposes. Distinct from clinical trials, registries provide insights into broader patient populations and re

0 views • 17 slides


Challenges in Medical Coding: A Critical Look at Errors and Solutions

Medical coding plays a crucial role in translating patient encounters into billable data, but incorrect coding poses significant challenges. Billing error rates are high, impacting providers, patients, and payers. Each step in the coding process has its issues, such as incomplete documentation and l

2 views • 5 slides


Understanding Digital Payments: Process and Security

Digital payments revolutionize the way transactions are conducted by enabling cashless transfers between payers and payees through various modes like banking cards, mobile wallets, and internet banking. This article delves into the concept of digital payments, different modes available, the pros and

0 views • 19 slides


September 7, 2024 - Payor Compliance: Report of Injury SROI Filings

The content discusses the Payor Compliance Subsequent Report of Injury (SROI) Filings scheduled for September 7, 2024. It covers various aspects including the bulletin notice, different SROI filings like Employer Paid (SROI EP), Initial Payment (SROI IP), Payment Report (SROI PY), and more. The Boar

1 views • 22 slides


Navigating Medicare and Employer Insurance Overlap

Individuals near Medicare eligibility while working or retired often seek HR guidance. However, HR may lack expertise on Medicare interaction, leading to gaps in coverage, penalties, and limitations. To avoid these issues, it's crucial to understand the client's employment status, Medicare eligibili

0 views • 36 slides


Introduction to Indiana's All-Payer Claims Data Base (APCD)

Indiana's All-Payer Claims Data Base (APCD) is a comprehensive state database comprising medical claims, pharmacy claims, eligibility information, and provider files from various health plans and insurers. The initiative aims to enhance healthcare policy-making, cost comparison, consumer information

0 views • 21 slides


Influence of Reportable Diagnoses on Quality of Care in Maryland

Accurate and appropriate documentation significantly impacts the quality of care provided to patients. Healthcare quality scores are now publicly reported and used by patients and private payers for decision-making. Organizations like CAPHIS, Health Care For All, HealthGrades, and NAHQ play crucial

0 views • 51 slides


Evolution of Customer Roles in Sustainable Business Development

The evolution of technology has empowered consumers to make informed choices and payments, transforming them into clients, consumers, and payers. Businesses must adapt to satisfy diverse customer desires in real-time to achieve sustainable development and create active customers. Shifting from sales

0 views • 23 slides


Understanding the Various Reasons for Giving

Explore the myriad reasons for giving, ranging from personal delight to societal obligations and external motivations. Delve into the diverse mindsets of donors, including joyful givers, tithers, dues payers, patrons, and more, as they contribute towards various causes and initiatives. Gain insights

0 views • 22 slides


Exploring Physical Activity Benefits Post Bariatric Surgery

Are the advantages of promoting physical activity after bariatric surgery worth the effort? Dr. Leah Schumacher delves into the outcomes and impact of metabolic and bariatric surgery (MBS) on patient satisfaction, safety, weight, co-morbidities, and quality of life. Understanding these factors is cr

0 views • 34 slides


Waste Management Financing Overview

Explore the intricacies of waste service fees, robust financing systems, determining waste service costs, and establishing a waste service fee. Learn about the Polluter Pays Principle and how waste management funding is essential for sustainable practices. Discover strategies to ensure fee collectio

0 views • 16 slides


Impact of Specialty Pharmacy Payer Changes on Hospital Operations

Specialty pharmacy payer changes, known as white bagging policy, have significant implications for hospitals and healthcare providers. These changes involve shifting from the traditional buy-and-bill method to obtaining medications through specialty pharmacies, leading to concerns about patient safe

0 views • 13 slides


Challenges and Opportunities in Oncology Drug Development: A Biostatistical Perspective

The field of oncology presents unique opportunities for advancing drug development through novel therapeutic modalities like immunotherapies, cell and gene therapies, and radioligand therapies. However, regulators, sponsors, and payers face criticism, often due to non-significant results in overall

0 views • 16 slides